ANIP FY 2007 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2007 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$493,054-96.6% YoY

Gross Profit

$493,054100.0% margin

Operating Income

-$9M-1760.3% margin

Net Income

-$8M-1538.3% margin

EPS (Diluted)

$-10.71

Cash Flow

Operating Cash Flow

$739,992

Free Cash Flow

$710,564

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$31M

Total Liabilities

$2M

Stockholders' Equity

$30M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$493,054	$14M	-96.6%
Gross Profit	$493,054	$14M	-96.6%
Operating Income	-$9M	$3M	-352.3%
Net Income	-$8M	$3M	-371.7%